FORT WORTH, Texas, Sept. 16 /PRNewswire-FirstCall/ -- Wound Care
Innovations, LLC, a subsidiary of Wound Management Technologies, Inc.
(OTC Bulletin Board: WNDM), announced today that it will be presenting at the
Georgetown University Hospital's Team Approach to Diabetic Limb Salvage (DLS)
conference in Washington DC September 18th-20th. The conference is intended
to better equip each member of the team with the resources needed to heal
wounds and prevent amputations. "We are delighted to be exhibiting at the DLS
conference," states Cathy Bradshaw, President of Wound Care Innovations.
"Diabetic wounds and the incidence of amputations is a serious issue in
healthcare. Attendees at this conference include the entire team who cares for
diabetics. This is a great opportunity for us to interact with the
participants and decision makers as well as the keeping up with the most
current information from leading authorities."
About Wound Management Technologies, Inc.:
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its
corporate headquarters in Fort Worth, Texas, markets and distributes wound
care products to the healthcare market under patented technology licensed to
the Company. The Company is positioned and seeks to be a leading provider of
wound care products. For more information on the Company please visit the
Company's Website at www.Celleraterx.com .
"Safe Harbor" Statement: Under The Private Securities Litigation Reform
Act of 1995: The statements in the press release that relate to the company's
expectations with regard to the future impact on the company's results from
new products in development are "forward-looking statements," within the
meaning of the Private Securities Litigation Reform Act of 1995. Since this
information may contain statements that involve risk and uncertainties and are
subject to change at any time, the company's actual results may differ
materially from expected results. This document may contain forward-looking
statements concerning the Company's operations, current and future performance
and financial condition. These items involve risks and uncertainties such as
product demand, market and customer acceptance, the effect of economic
conditions, competition, pricing, the ability to consummate and integrate
acquisitions, and other risks and uncertainties detailed in the Company's SEC
filings. The Company undertakes no obligation to revise any of these
statements to reflect the future circumstances or the occurrence of
unanticipated events.
For Further Information:
Product Information Shareholder Relations
Cathy Bradshaw Lucy Singleton
President Secretary
954-315-9242 817-820-7080
SOURCE Wound Management Technologies, Inc.
